News

Precigen Announces Positive Phase 1 Data for PRGN-3005 Autologous UltraCAR-T® Cells Manufactured Overnight for Infusion Next Day to Advanced Stage Platinum Resistant Ovarian Cancer Patients

by

“We are pleased with the results of the Phase 1 study which demonstrate a favorable safety profile for PRGN-3005 UltraCAR-T. Our UltraCAR-T therapies continue to be well-tolerated with no dose limiting toxicities across our clinical stage UltraCAR-T portfolio,” said Helen Sabzevari, PhD, President and CEO of Precigen. “At this early stage, we are encouraged that … Read more

Careismatic Brands, Inc. Acquires BALA Footwear

by

The performance shoe company joins Careismatic’s portfolio of innovative medical apparel brands. SANTA MONICA, Calif., June 5, 2023 /PRNewswire/ — Careismatic Brands, Inc., one of the world’s largest medical apparel companies, announced today that it has acquired BALA footwear, a nursing footwear company. BALA provides dynamic, high-performance shoes that enable healthcare workers to focus on … Read more

Hapbee Announces Closing of $710K Private Placement

by

VANCOUVER, BC, June 5, 2023 /PRNewswire/ – Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company“), the digital wellness technology company is pleased to announce that it has completed a non-brokered private placement of units of the Company (“Units“) for aggregate gross proceeds to the Company of CAD$711,400 (the “Offering“). “This … Read more

Waters et Sartorius élargissent le champ de leur collaboration afin d’offrir une bioanalyse complète pour la fabrication en aval de produits biologiques USA – Français USA – español APAC – English USA – Deutsch USA – English USA – English

by

Résumé de l’article : Intégration de la chromatographie multicolonnes à l’échelle des procédés de Sartorius à la technologie analytique des procédés de Waters afin de fournir des données analytiques solides pour la biofabrication en aval d’AcM, de protéines recombinantes, de vaccins et d’autres produits biologiques. Cette solution intégrée permet d’obtenir des données analytiques essentielles en quelques … Read more

BIOLASE ANNOUNCES DISTRIBUTION OF SERIES I PREFERRED STOCK TO HOLDERS OF ITS COMMON STOCK

by

LAKE FOREST, Calif., June 5, 2023 /PRNewswire/ — BIOLASE, Inc. (NASDAQ: BIOL) (“BIOLASE” or the “Company”), a global leader in dental lasers, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly-designated Series I Preferred Stock, par value $0.001 per share, for each outstanding share of BIOLASE common stock held of … Read more

Children’s Hospital of Philadelphia Celebrates 27th Annual Fetal Surgery Family Reunion at the Philadelphia Zoo

by

PHILADELPHIA, June 5, 2023 /PRNewswire/ — Yesterday, more than 3,000 people gathered at the Philadelphia Zoo to celebrate the 27th Children’s Hospital of Philadelphia (CHOP) Fetal Family Reunion, representing patients and families from across the country. The event, hosted by CHOP’s Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment (CFDT), provides an opportunity for those treated … Read more

Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

by

CAMBRIDGE, Mass., June 5, 2023 /PRNewswire/ — Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective June 1, 2023, the Compensation Committee of Blueprint Medicines’ Board of Directors granted non-qualified stock options to purchase an aggregate of 7,593 shares of its common stock and an aggregate of 3,796 restricted stock units (RSUs) to six new … Read more

Greenbrook TMS Announces Receipt of Statement of Claim

by

TORONTO, June 5, 2023 /PRNewswire/ – Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company“) announced today that the sellers of Check Five LLC (d/b/a “Success TMS”) (“Success TMS“) have filed a complaint in the Superior Court of the State of Delaware against the Company, TMS NeuroHealth Centers, Inc. (“TMS NeuroHealth Centers“) and certain executive … Read more

Nevro Names New Chief Commercial Officer

by

Organizational Change Designed to Drive Strong Growth and Advance Global Commercial Focus Company Updates Second Quarter 2023 Revenue Guidance REDWOOD CITY, Calif., June 5, 2023 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that Greg Siller has been appointed Senior … Read more

FOUNDATION OF HOPE GIVES ALMOST $1 MILLION TO MENTAL ILLNESS RESEARCH

by

RALEIGH, N.C., June 5, 2023 /PRNewswire/ — Continuing efforts to curb the debilitating effects of mental illness, the Foundation of Hope for Research and Treatment of Mental Illness (FOH) has approved over $987,000 in research grants to fourteen investigators in the Department of Psychiatry at The University of North Carolina at Chapel Hill. The recipients … Read more